Extendicare (TSE:EXE) Announces Earnings Results

Extendicare (TSE:EXE) announced its earnings results on Thursday. The company reported C$0.41 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of C$627.84 million for the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%.

Extendicare Stock Down 2.4%

EXE stock opened at C$27.15 on Friday. The company has a market cap of C$2.58 billion, a price-to-earnings ratio of 20.79 and a beta of 1.31. Extendicare has a twelve month low of C$15.80 and a twelve month high of C$39.14. The business has a 50 day moving average price of C$29.00 and a two-hundred day moving average price of C$30.00. The company has a quick ratio of 0.98, a current ratio of 0.75 and a debt-to-equity ratio of 159.54.

Extendicare Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Monday, November 16th. Shareholders of record on Monday, November 16th will be paid a $0.0441 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Friday, October 30th. Extendicare’s dividend payout ratio (DPR) is currently 39.23%.

Analysts Set New Price Targets

EXE has been the subject of several research reports. National Bank Financial decreased their price target on shares of Extendicare from C$45.00 to C$40.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. Royal Bank Of Canada boosted their price objective on shares of Extendicare from C$38.00 to C$39.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Canaccord Genuity Group increased their target price on shares of Extendicare from C$37.00 to C$44.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Desjardins reduced their target price on shares of Extendicare from C$40.00 to C$39.00 and set a “buy” rating for the company in a report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of C$37.00.

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.